ME

23Andme Holding Co
NASDAQ
2.520
-0.010
-0.40%
After Hours: 2.760 +0.24 +9.52% 19:51 02/08 EST
OPEN
2.510
PREV CLOSE
2.530
HIGH
2.580
LOW
2.471
VOLUME
2.31M
TURNOVER
0
52 WEEK HIGH
6.31
52 WEEK LOW
2.020
MARKET CAP
1.15B
P/E (TTM)
-2.1113
1D
5D
1M
3M
1Y
5Y
BRIEF-23Andme Reports Fy2023 Third Quarter Financial Results
Reuters · 13h ago
23andMe Stock Jumps More Than 12% On Raised 2023 Guidance -- MarketWatch
MarketWatch · 14h ago
23andMe stock jumps more than 12% on raised 2023 guidance
MarketWatch · 14h ago
23andMe up 12% on 2023 outlook raise, quarterly beats
Seeking Alpha · 14h ago
23andMe Holding Q3 EPS $(0.20) Misses $(0.19) Estimate, Sales $66.94M Beat $65.90M Estimate
Benzinga · 14h ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 14h ago
A Preview Of 23andMe Holding's Earnings
Benzinga · 1d ago
23andMe Holding Launches $150 Million At-the-Market Offering; Files $500 Million Mixed Shelf
23andMe Holding Launches $150 Million At-the-Market Offering; Files $500 Million Mixed Shelf
MT Newswires · 2d ago
More
About ME
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company's segments include Consumer & Research Services and Therapeutics. The Consumer & Research Services segment comprises its Personal Genome Service (PGS), telehealth business, and research services. Its PGS service provides customers with a suite of genetic reports, including information on customers genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. Its telehealth platform provides patients with access to medical consultation and treatment. Through its research services, it uses its database of genetic and phenotypic information to identify targets for drug development. The Therapeutics segment focuses on the use of genetic insights from its database of genetic and phenotypic information to develop therapies to improve patients lives.

Webull offers kinds of 23andMe Holding Co. stock information, including NASDAQ:ME real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ME stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ME stock methods without spending real money on the virtual paper trading platform.